arXiv:2611.14956v1 Announce Type: new
Abstract: Discovering hit molecules requires not just high binding affinity, but also the identification of diverse binding modes, which are critical for experimental assays. Existing generative approaches have predominantly relied on optimizing a scalar docking score, obscuring the distinct contributions of key binding determinants. To this end, we introduce a paradigm shift by formulating target-based drug design as a multi-objective exploration task, where each objective explicitly corresponds to enhancing interactions with a specific hotspot. Here, we introduce BindMol, a novel generative framework driven by a customized multi-objective reinforcement learning algorithm. By incorporating explorative preferences during training, our approach efficiently uncovers molecules with diverse and desirable binding profiles. Empirical results demonstrate that BindMol facilitates the discovery of high-affinity compounds characterized by both structural novelty and diverse binding modes. Validated across target-based drug discovery and multi-property optimization tasks, our approach provides a versatile paradigm for goal-oriented drug discovery.
Trending
- AI is “the most likely reason” you’ll die, OpenAI board member warns
- Helping with the problem behind the question
- The Microsoft Outage Is a Warning for the World
- Binding Mode Matters: Hotspot-Aware Drug Discovery via Explorative Preferences
- Meta’s Muse now calls businesses for you, but many companies might just hang up on the AI
- [2611.17225] Data Archive for 2D and 3D Electrical Impedance Tomography with moderate conductivity contrast phantoms
- Open-Source Text Generation & LLM Ecosystem at Hugging Face
- Microsoft Services Are Returning After An Outage Took Down Outlook, Teams And More
